PROTHENA CORP PUBLIC LTD CO current report, 28 October 2022

Business Context and Reporting Period

Company: Prothena Corporation plc (PRTA)
Filing Type: Form 8-K (Current Report)
Date of Report: October 28, 2022
Event: Entry into a Material Definitive Agreement (Sublease of office and laboratory space).

Key Financial Metrics and Agreement Terms

This filing details a specific lease agreement rather than general financial performance. Key financial terms include:

  • Facility Size: Approximately 31,157 square feet in Brisbane, California.
  • Lease Term: Terminates September 30, 2028.
  • Rent Commencement: July 1, 2023.
  • Base Rent: Approximately $241,466.75 per month in the first year, increasing by approximately 3.5% annually thereafter.
  • Rent Abatement: Monthly base rent is abated for the first six months after the Rent Commencement Date.
  • Improvement Allowance: Approximately $9,347,100.00 for hard costs, design, construction management, and permits.
  • Security: Standby letter of credit in the initial amount of approximately $860,360.25.

Material Changes Versus Prior Period

The filing does not provide comparative financial data or material changes to prior periods. It reports a new contractual obligation entered into on October 28, 2022.

Guidance, Outlook, and Risks

Management Commentary: The Company entered into the Sublease to secure office and laboratory space for its subsidiary, Prothena Biosciences Inc. The agreement includes customary indemnification provisions regarding the use and construction of improvements on the facility.

Risks and Contingencies:

  • The Sublease may be terminated earlier than September 30, 2028.
  • The Sublandlord may draw down the standby letter of credit if the Company defaults on provisions after the applicable cure period.
  • The Company is obligated to pay certain costs, taxes, and operating expenses related to the facility, subject to exclusions.

Important Facts for Investor Verification

  • Verify the impact of the new lease obligations on future cash flow starting July 1, 2023.
  • Confirm the utilization of the $9.35 million improvement allowance and associated capital expenditure plans.
  • Review the full text of the Sublease and Consent Agreement filed as exhibits to the Form 10-K for the year ended December 31, 2022.
  • Monitor the Company's liquidity to ensure the standby letter of credit requirement ($860,360.25) is maintained.